{"id":42712,"date":"2019-06-26T11:00:09","date_gmt":"2019-06-26T02:00:09","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=42712"},"modified":"2019-06-25T15:13:53","modified_gmt":"2019-06-25T06:13:53","slug":"sumitomo-dainippon-pharma-adopts-veeva-vault-rim-to-streamline-global-regulatory-submissions","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/sumitomo-dainippon-pharma-adopts-veeva-vault-rim-to-streamline-global-regulatory-submissions\/","title":{"rendered":"\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3001Veeva Vault RIM\u3092\u5c0e\u5165\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u85ac\u4e8b\u7533\u8acb\u3092\u5408\u7406\u5316"},"content":{"rendered":"<p style=\"text-align: right;\">2019\u5e746\u670826\u65e5<\/p>\n<p style=\"text-align: right;\">Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b \u300cVeeva\u300d)\u306f\u3001\u672c\u65e5\u3001\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e \uff1a\u5927\u962a\u5e02\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577 :\u3000\u91ce\u6751 \u535a\u3001\u4ee5\u4e0b\u300c\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u300d\uff09\u304c\u85ac\u4e8b\u7533\u8acb\u30d7\u30ed\u30bb\u30b9\u3092\u4e00\u5143\u5316\u3059\u308b\u305f\u3081\u306b\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-submissions\/\">Vault Submissions<\/a><\/strong>\u3068<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-submissions-archive\/\">Vault Submissions Archive<\/a><\/strong>\u3092\u3001\u6628\u5e74\u306b\u5b9f\u88c5\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-rim\/\">Vault RIM Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3042\u308bVault Submissions\u3068Vault Submissions Archive\u306b\u3088\u3063\u3066\u3001\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u306f\u7533\u8acb\u6587\u66f8\u4f5c\u6210\u7528\u306b\u4e00\u5143\u5316\u3055\u308c\u305f\u60c5\u5831\u6e90\u3092\u6301\u3061\u3001\u898f\u5236\u5f53\u5c40\u304b\u3089\u306e\u8981\u8acb\u306b\u5bfe\u3057\u3055\u3089\u306b\u8fc5\u901f\u306b\u5fdc\u3048\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"http:\/\/www.veeva.com\/resources\/sumitomo-dainippon-pharma-adopts-veeva-vault-rim-to-streamline-global-regulatory-submissions\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u306e\u958b\u767a\u85ac\u4e8b\u90e8\u9577\u3067\u3042\u308b\u5927\u8c37\u61b2\u4e00\u69d8\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u300cVeeva\u306f\u3001\u7533\u8acb\u696d\u52d9\u306e\u5408\u7406\u5316\u3092\u5b9f\u73fe\u3057\u3001\u4e16\u754c\u4e2d\u306e\u85ac\u4e8b\u898f\u5236\u30d7\u30ed\u30bb\u30b9\u306e\u53ef\u8996\u6027\u5411\u4e0a\u306b\u5bc4\u4e0e\u3059\u308b\u3001\u6700\u9ad8\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u63d0\u4f9b\u3057\u3066\u304f\u308c\u307e\u3059\u3002Veeva Vault Submissions\u3068Vault Submissions Archive\u306f\u3001\u30d7\u30ed\u30bb\u30b9\u306e\u7c21\u7d20\u5316\u3068\u9023\u643a\u5f37\u5316\u306b\u5f79\u7acb\u3061\u3001\u898f\u5236\u5f53\u5c40\u3078\u306e\u5bfe\u5fdc\u696d\u52d9\u306e\u52b9\u7387\u5316\u304c\u671f\u5f85\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n<p>\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u3067\u306f\u3053\u308c\u307e\u3067\u3001\u85ac\u4e8b\u7533\u8acb\u306e\u7ba1\u7406\u306b\u3055\u307e\u3056\u307e\u306a\u30b7\u30b9\u30c6\u30e0\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u4f7f\u7528\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u305d\u308c\u3092Veeva Vault RIM\u3067\u4e00\u5143\u5316\u3057\u305f\u3053\u3068\u3067\u3001\u540c\u793e\u306f\u7533\u8acb\u8a08\u753b\u304b\u3089\u6587\u66f8\u4f5c\u6210\u30fb\u4fdd\u7ba1\u306b\u3044\u305f\u308b\u307e\u3067\u306e\u3001\u3042\u3089\u3086\u308b\u7533\u8acb\u696d\u52d9\u306b\u5bfe\u5fdc\u3057\u305fSingle Source of Truth\u3092\u5b9f\u73fe\u3067\u304d\u307e\u3057\u305f\u3002\u305d\u3057\u3066\u3001\u4e16\u754c\u4e2d\u306e\u85ac\u4e8b\u7533\u8acb\u696d\u52d9\u306e\u30a2\u30af\u30bb\u30b9\u3092\u901a\u3058\u3066\u3001\u3088\u308a\u5bb9\u6613\u306b\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>Vault Submissions\u306e\u5b9f\u7528\u7684\u306a\u30ec\u30dd\u30fc\u30c8\u3068\u30c0\u30c3\u30b7\u30e5\u30dc\u30fc\u30c9\u306b\u3088\u308a\u3001\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u306f\u7533\u8acb\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u9032\u6357\u72b6\u6cc1\u3068\u3001\u5404\u7533\u8acb\u306e\u5168\u72b6\u614b\u3092\u7dbf\u5bc6\u306b\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002Vault Submissions\u306f\u3001\u4e3b\u8981\u306a\u5168\u7533\u8acb\u30bf\u30a4\u30d7\u3068\u3001\u5404\u56fd\u56fa\u6709\u306e\u5909\u66f4\u306b\u5bfe\u5fdc\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001Vault Submissions Archive\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u540c\u793e\u306f\u85ac\u4e8b\u7533\u8acb\u696d\u52d9\u306e\u5b8c\u74a7\u306a\u5c65\u6b74\u3092\u96e3\u306a\u304f\u62bd\u51fa\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u73fe\u5730\u898f\u5236\u5f53\u5c40\u3068\u306e\u3084\u308a\u53d6\u308a\u3092\u3088\u308a\u8fc5\u901f\u304b\u3064\u6b63\u78ba\u306b\u9032\u3081\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>Veeva Japan\u306e\u4ee3\u8868\u53d6\u7de0\u5f79\u3067\u3042\u308b\u5ca1\u6751\u5d07\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cVeeva Vault RIM Suite\u306b\u3088\u308a\u3001\u88fd\u85ac\u4f01\u696d\u306f\u85ac\u4e8b\u696d\u52d9\u5168\u822c\u3067\u3001\u3055\u3089\u306a\u308b\u52b9\u7387\u5316\u3092\u63a8\u9032\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u5f53\u793e\u306f\u3001\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u69d8\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u7533\u8acb\u30d7\u30ed\u30bb\u30b9\u3092\u5186\u6ed1\u5316\u3059\u308b\u305f\u3081\u306b\u3001\u30b5\u30dd\u30fc\u30c8\u3067\u304d\u308b\u3053\u3068\u3092\u5149\u6804\u306b\u601d\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>Vault RIM Suite\u306f\u627f\u8a8d\u7533\u8acb\u304a\u3088\u3073\u898f\u5236\u5f53\u5c40\u306b\u5bfe\u3059\u308b\u6587\u66f8\u4f5c\u6210\u696d\u52d9\u3068\u5408\u610f\u5f62\u6210\u3001\u7533\u8acb\u66f8\u985e\u3068\u516c\u958b\u6e08\u307f\u306e\u66f8\u985e\u306e\u3059\u3079\u3066\u3092\u7ba1\u7406\u3067\u304d\u308b\u5b8c\u5168\u306b\u7d71\u5408\u3055\u308c\u305fRIM\u6a5f\u80fd\u3092\u3001\u5358\u4e00\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u63d0\u4f9b\u3057\u307e\u3059\u3002Vault RIM\u3092\u305d\u306e\u4e00\u90e8\u3068\u3057\u3066\u542b\u3080\u3001\u4e00\u5143\u5316\u3055\u308c\u305f\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u3042\u308b<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/development-cloud\/\">Veeva Development Cloud<\/a><\/strong>\u306f\u3001\u81e8\u5e8a\u958b\u767a\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u4fdd\u8a3c\u306e\u5404\u696d\u52d9\u306b\u5bfe\u5fdc\u3057\u3001\u4f01\u696d\u304c\u7814\u7a76\u958b\u767a\u3068\u88fd\u9020\u306e\u5168\u4f53\u306b\u308f\u305f\u308b\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306a\u30d3\u30b8\u30cd\u30b9\u30d7\u30ed\u30bb\u30b9\u3092\u4fc3\u9032\u3059\u308b\u30b5\u30dd\u30fc\u30c8\u3092\u3057\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/DevelopmentCloud\">veeva.com\/jp\/DevelopmentCloud<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\n\u5927\u65e5\u672c\u4f4f\u53cb\u88fd\u85ac\u306f\u3001\u300c\u4eba\u3005\u306e\u5065\u5eb7\u3067\u8c4a\u304b\u306a\u751f\u6d3b\u306e\u305f\u3081\u306b\u3001\u7814\u7a76\u958b\u767a\u3092\u57fa\u76e4\u3068\u3057\u305f\u65b0\u305f\u306a\u4fa1\u5024\u306e\u5275\u9020\u306b\u3088\u308a\u3001\u5e83\u304f\u793e\u4f1a\u306b\u8ca2\u732e\u3059\u308b\u300d\u3053\u3068\u3092\u4f01\u696d\u7406\u5ff5\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u7406\u5ff5\u3092\u5b9f\u73fe\u3059\u308b\u305f\u3081\u3001\u307e\u305f\u3001\u65e5\u672c\u306f\u3082\u3061\u308d\u3093\u4e16\u754c\u306e\u65b9\u3005\u306b\u9769\u65b0\u7684\u3067\u6709\u7528\u306a\u533b\u85ac\u54c1\u3092\u304a\u5c4a\u3051\u3059\u308b\u305f\u3081\u3001\u65b0\u85ac\u306e\u7814\u7a76\u958b\u767a\u306b\u5168\u529b\u3092\u6ce8\u3044\u3067\u3044\u307e\u3059\u3002\u30a2\u30f3\u30e1\u30c3\u30c8\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30cb\u30fc\u30ba\u306e\u9ad8\u3044\u7cbe\u795e\u795e\u7d4c\u9818\u57df\u3001\u304c\u3093\u9818\u57df\u304a\u3088\u3073\u518d\u751f\u30fb\u7d30\u80de\u533b\u85ac\u5206\u91ce\u3092\u7814\u7a76\u91cd\u70b9\u9818\u57df\u3068\u3057\u3001\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u306e\u5275\u88fd\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f<a href=\"https:\/\/www.ds-pharma.co.jp\/\"><strong>https:\/\/www.ds-pharma.co.jp\/<\/strong><\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067750\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<strong><a href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended April 30, 2019. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2019\u5e746\u670826\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e &nbsp; Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42712","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42712"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42712"}],"version-history":[{"count":4,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42712\/revisions"}],"predecessor-version":[{"id":42720,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42712\/revisions\/42720"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}